細胞組織工学の世界市場:用途別(臍帯血および細胞バンキング、癌、消化器及び婦人科、歯科、整形外科、筋骨格及び脊椎)、地域別

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GV20MY124)
◆英語タイトル:Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Orthopedics, Musculoskeletal, & Spine), By Region, And Segment Forecasts, 2020 - 2027
◆発行会社/調査会社:Grand View Research
◆商品コード:GV20MY124
◆発行日:2020年3月11日
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[細胞組織工学の世界市場:用途別(臍帯血および細胞バンキング、癌、消化器及び婦人科、歯科、整形外科、筋骨格及び脊椎)、地域別]についてメールでお問い合わせはこちら
本調査レポートでは、細胞組織工学の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場要因・動向・範囲、用途別(臍帯血および細胞バンキング、癌、GI、歯科、皮膚および外皮、泌尿器科、整形外科、筋骨格、脊椎、神経学、循環器、血管、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東及びアフリカ)分析、競争状況などの構成でお届けいたします。
・調査手法
・エグゼクティブサマリー
・市場要因・動向・範囲
・細胞組織工学の世界市場:用途別(臍帯血および細胞バンキング、癌、GI、歯科、皮膚および外皮、泌尿器科、整形外科、筋骨格、脊椎、神経学、循環器、血管、その他)
・細胞組織工学の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東及びアフリカ)
・競争状況
*** レポート概要(サマリー)***

The global tissue engineering market size is expected to reach USD 28.9 billion by 2027, expanding at a CAGR of 14.2%, according to a new report by Grand View Research, Inc. Allogenic tissue transplant method efficiently addresses challenges and limitations regarding the implementation and availability of autologous transplants. Moreover, the development of specialized procedures including implant fixing and sterilization to transform allogeneic implants so for application as biostatic implants is expected to drive revenue generation in this market.

Rapid advancements and a strong pipeline of regenerative medicine are anticipated to provide effective solutions for chronic conditions. Several companies in growing markets are striving to capitalize on the untapped market potential with a strong focus on R&D. For instance, RepliCel is investing in multiple regenerative medicine products. As of 2019, its three products (RCH-01, RCS-01, RCT-01) were in the development phase and its dermal injector device (RCI-02) is under pre-commercialization production and testing phase.

The application of nanotechnology has played a critical role in the process of tissue engineering. Treating neurological diseases is a significant challenge as early diagnosis and treatment initiation is crucial. However, the advent of new 3D designed nanofibers has proved to be a ready alternative to aid the regeneration of damaged neurons. Such advances have propelled the growth of tissue engineering products.

Further key findings from the report suggest:

• Cardiology and vascular application is one of the fastest-growing segments owing to an increasing incidence rate of heart failures worldwide

• Since the past 20 years, cardiac cell therapy or cardiomyoplasty has been an important focal point of the majority of the studies aimed at heart disease management through regeneration

• A rise in the number of children with congenital malformations such as single ventricle anomalies has led to the growing demand for heart transplantation

• Tissue-engineered organs help address challenges related to the lack of suitable donor organ and potential side effects related to the transplantation, thereby driving the tissue engineering market growth

• Orthopedic, musculoskeletal, and spine segment accounted for the major revenue share in 2019 and is anticipated to dominate the market for tissue engineering through 2027

• The high share is attributable to frequent damage to musculoskeletal tissues or loss of tissue in disease or injury with limited repair probability

• In addition, a rise in geriatric population, increasing sports-related injuries, and musculoskeletal disorders is also responsible for a high share of orthopedic, musculoskeletal, and spine segment

• The lucrative opportunities proposed by emerging economies have drawn the attention of global leaders for investing in the Asia Pacific region. This is attributable to the fastest growth of the market for tissue engineering in the Asia Pacific region throughout the forecast period

• Medtronic plc; Zimmer Biomet Holdings, Inc; Allergan plc; Athersys, Inc; ACell, Inc.; Stryker Corporation; Integra LifeSciences Corporation; and Baxter International, Inc. are the key players operating in the market for tissue engineering

• These participants are engaged in strategic alliances, deals, and development of novel products to sustain their market share.

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.1.3 Secondary sources:
1.2 Third party perspective:
1.2.1 Primary research:
1.3 Sample size for the study on Tissue Engineering Market:
1.3.1 Primary Sources
1.3.2 Manufacturers -
1.3.3 Secondary Sources
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Objectives
1.6.1 Objective 1
1.6.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Market Snapshot, 2019, (USD Million)
Chapter 3 Tissue Engineering Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.1.2.1 Stem cell market
3.1.2.2 3D cell culture market
3.2 Market Segmentation and Scope
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Advancements in stem cell technology & tissue engineering
3.3.1.1.1 Nanotechnology potential
3.3.1.1.2 Technological advancements in biological implants
3.3.1.1.3 Introduction of novel platforms and technologies
3.3.1.2 Rise in number of clinical studies for regenerative medicine and tissue engineering
3.3.1.3 Increasing tissue engineering research funding
3.3.2 Market restraint analysis
3.3.2.1 High cost of product development
3.3.2.2 Ethical concerns related to stem cell research & tissue engineered product
3.3.2.3 Clinical issues pertaining to development & implementation of stem cell therapies
3.3.2.3.1 Manufacturing issues
3.3.2.3.2 Genetic instability
3.3.2.3.3 Condition of stem cell culture
3.3.2.3.4 Stem cell distribution after transplant
3.3.2.3.5 Immunological rejection
3.3.2.3.6 Challenges associated with allogenic mode of transplantation
3.4 Penetration & Growth Prospects Mapping, by Application, 2019
3.5 Tissue Engineering Market – PESTEL Analysis
3.6 Industry Analysis – Porter’s
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Collaboration & agreement
3.7.2 Joint venture
Chapter 4 Tissue Engineering Market: Application Estimates & Trend Analysis
4.1 Tissue Engineering Market: Application Movement Analysis
4.2 Cord Blood & Cell Banking
4.2.1 Cord Blood & Cell Banking Market, 2016 – 2027 (USD Million)
4.3 Cancer
4.3.1 Cancer Market, 2016 – 2027 (USD Million)
4.4 Gastrointestinal Disorders (GI) and Gynecology
4.4.1 GI & Gynecology Market, 2016 – 2027 (USD Million)
4.5 Dental
4.5.1 Dental Market, 2016 – 2027 (USD Million)
4.6 Skin & Integumentary
4.6.1 Skin & Integumentary Market, 2016 – 2027 (USD Million)
4.7 Urology
4.7.1 Urology Market, 2016 – 2027 (USD Million)
4.8 Orthopedics, Musculoskeletal, & Spine
4.8.1 Orthopedics, Musculoskeletal, & Spine Market, 2016 – 2027 (USD Million)
4.9 Neurology
4.9.1 Neurology Market, 2016 – 2027 (USD Million)
4.10 Cardiology & Vascular
4.10.1 Cardiology & Vascular Market, 2016 – 2027 (USD Million)
4.11 Others
4.11.1 Tissue Engineering Market for Other Applications, 2016 – 2027 (USD Million)
Chapter 5 Tissue Engineering Market: Regional Estimates & Trend Analysis, by Application
5.1 Tissue Engineering Market Share by Region, 2019 & 2027
5.2 North America
5.2.1 North America Tissue Engineering Market, 2016 – 2027 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. tissue engineering market, by application, 2016 – 2027 (USD Million)
5.2.3 Canada
5.2.3.1 Canada tissue engineering market, by application, 2016 – 2027 (USD Million)
5.3 Europe
5.3.1 Europe Tissue Engineering Market, by application, 2016 – 2027 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. tissue engineering market, by application, 2016 – 2027 (USD Million)
5.3.3 Germany
5.3.3.1 Germany tissue engineering market, by application, 2016 – 2027 (USD Million)
5.3.4 France
5.3.4.1 France tissue engineering market, by application, 2016 – 2027 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Tissue Engineering Market, 2016 – 2027 (USD Million)
5.4.2 Japan
5.4.2.1 Japan tissue engineering market, by application, 2016 – 2027 (USD Million)
5.4.3 China
5.4.3.1 China tissue engineering market, by application, 2016 – 2027 (USD Million)
5.4.4 India
5.4.4.1 India tissue engineering market, by application, 2016 – 2027 (USD Million)
5.5 Latin America
5.5.1 Latin America Tissue Engineering Market, 2016 – 2027 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Tissue engineering market, by application, 2016 – 2027 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico tissue engineering market, by application, 2016 – 2027 (USD Million)
5.6 MEA
5.6.1 MEA Tissue Engineering Market, 2016 – 2027 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa tissue engineering market, by application, 2016 – 2027 (USD Million)
Chapter 6 Competitive Landscape
6.1 Company Categorization
6.2 Tissue Engineering Market Position Analysis (Based on Products, Market Presence, Service Portfolio, Regional Presence)
6.3 List of key players (public and private) operating in the tissue engineering market
6.4 Strategy Framework
6.5 Company Profiles
6.5.1 Medtronic plc
6.5.1.1 Company overview
6.5.1.2 Financial performance
6.5.1.3 Product benchmarking
6.5.1.4 Strategic initiatives
6.5.2 Zimmer Biomet Holdings, Inc.
6.5.2.1 Company overview
6.5.2.2 Financial performance
6.5.2.3 Product benchmarking
6.5.2.4 Strategic initiatives
6.5.3 Allergan plc
6.5.3.1 Acelity L.P. Inc. (LifeCell)
6.5.3.2 Company overview
6.5.3.3 Financial performance
6.5.3.3.1 Financial performance: Acility
6.5.3.4 Product benchmarking
6.5.3.5 Strategic initiatives
6.5.4 ACell, Inc.
6.5.4.1 Company overview
6.5.4.2 Product benchmarking
6.5.4.3 Strategic initiatives
6.5.5 Athersys, Inc.
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.6 Organogenesis Holdings Inc.
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product Benchmarking
6.5.6.4 Strategic initiatives
6.5.7 Stryker Corporation
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.7.4 Strategic initiatives
6.5.8 Tissue Regenix Group plc
6.5.8.1 Company overview
6.5.8.2 Financial performance
6.5.8.3 Product benchmarking
6.5.8.4 Strategic initiatives
6.5.9 RTI Surgical, Inc.
6.5.9.1 Company overview
6.5.9.2 Financial performance
6.5.9.3 Product benchmarking
6.5.9.4 Strategic initiatives
6.5.10 ReproCell, Inc.
6.5.10.1 Company overview
6.5.10.2 Product benchmarking
6.5.10.3 Strategic initiatives
6.5.11 Integra LifeSciences Corporation
6.5.11.1 Company overview
6.5.11.2 Financial performance
6.5.11.3 Product benchmarking
6.5.11.4 Strategic initiatives
6.5.12 Baxter International, Inc.
6.5.12.1 Company overview
6.5.12.1.1 Synovis Micro Companies Alliance, Inc.
6.5.12.2 Financial performance
6.5.12.3 Product benchmarking


List of Tables

Table 1 Global precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 2 Precast structural building components market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 3 Precast architectural building components market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 4 Precast transportation products market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 5 Water and waste handling products market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 6 Other precast concrete products market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 7 Precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 8 Precast concrete market estimates and forecasts, in residential, 2016 - 2027 (USD Million)
Table 9 Precast concrete market estimates and forecasts, in non-residential, 2016 - 2027 (USD Million)
Table 10 Precast concrete market estimates and forecasts, in infrastructure, 2016 - 2027 (USD Million)
Table 11 Precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 12 North America precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 13 North America precast concrete market estimates and forecasts, by material, 2016 - 2027 (USD Million)
Table 14 North America precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 15 U.S. precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 16 U.S. precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 17 U.S. precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 18 Europe precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 19 Europe precast concrete market estimates and forecasts, by material, 2016 - 2027 (USD Million)
Table 20 Europe precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 21 Germany precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 22 Germany precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 23 Germany precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 24 France precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 25 France precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 26 France precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 27 U.K. precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 28 U.K. precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 29 U.K. precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 30 Italy precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 31 Italy precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 32 Italy precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 33 Asia Pacific precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 34 Asia Pacific precast concrete market estimates and forecasts, by material, 2016 - 2027 (USD Million)
Table 35 Asia Pacific precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 36 China precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 37 China precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 38 China precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 39 India precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 40 India precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 41 India precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 42 Japan precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 43 Japan precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 44 Japan precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 45 South Korea precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 46 South Korea precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 47 South Korea precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 48 Central & South America precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 49 Central & South America precast concrete market estimates and forecasts, by material, 2016 - 2027 (USD Million)
Table 50 Central & South America precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 51 Brazil precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 52 Brazil precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 53 Brazil precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 54 Middle East & Africa precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 55 Middle East & Africa precast concrete market estimates and forecasts, by material, 2016 - 2027 (USD Million)
Table 56 Middle East & Africa precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)
Table 57 Saudi Arabia precast concrete market estimates and forecasts, 2016 - 2027 (USD Billion)
Table 58 Saudi Arabia precast concrete market estimates and forecasts, by product type, 2016 - 2027 (USD Billion)
Table 59 Saudi Arabia precast concrete market estimates and forecasts, by end-use, 2016 - 2027 (USD Billion)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Primary Research Process
Fig. 4 Primary Research Approaches
Fig. 5 Market Snapshot
Fig. 6 Precast Concrete Market - Market Segmentation
Fig. 7 Penetration and Growth Prospect Mapping
Fig. 8 Precast Concrete Market - Value Chain Analysis
Fig. 9 Precast Concrete Market - Market Dynamics
Fig. 10 Market Driver Analysis
Fig. 11 Global construction spending by country, 2012 (USD Billion) & CAGR, 2013 - 2018 (%)
Fig. 12 Cost Comparison of Precast and Cast-in Site Concrete
Fig. 13 Global prefab or offsite construction growth rate (%)
Fig. 14 Market Restraint Analysis
Fig. 15 Key opportunities prioritized
Fig. 16 New Market Avenues
Fig. 17 Precast Concrete Market: Product Type Movement Analysis, 2019 & 2027
Fig. 18 Precast Concrete Market: End-Use Movement Analysis, 2019 & 2027
Fig. 19 Precast Concrete Market: Regional Market Snapshot
Fig. 20 Precast Concrete Market: End-Use Movement Analysis, 2019 & 2027
Fig. 21 Precast Concrete Market: Competitive environment
Fig. 22 Precast Concrete Market: End-Use Movement Analysis, 2019 & 2027
Fig. 23 Strategic framework

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GV20MY124 )"細胞組織工学の世界市場:用途別(臍帯血および細胞バンキング、癌、消化器及び婦人科、歯科、整形外科、筋骨格及び脊椎)、地域別" (英文:Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Orthopedics, Musculoskeletal, & Spine), By Region, And Segment Forecasts, 2020 - 2027)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。